competitor analysis: biosimilar and biosuperior therapeutic antibodies 2014

www.MarketResearchReports.com

Competitor Analysis: Biosimilar and

Biosuperior Therapeutic

Antibodies 2014

Category : Pharma & Healthcare

All logos and Images mentioned on this slide belong to their respective owners.

http://www.marketresearchreports.com/


Introduction to Report

Launch Date: March 11, 2014

Number of Pages: 386

Geography Coverage: Global

Available Format: PDF

Price For Single User License: USD 1,514

Price For Single Site License: USD 3,028

Price For Global User License: USD 4,543

Delivery Time: Within 24 Hours (During Working Days)



About the Report

The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of March 2014.

Marketed antibodies are attractive for companies to create next generation variants and biosimilar copies because they represent clinically and commercially validated products. New technologies such as Fc engineering, polyclonal mixtures, antibody drug conjugates or bispecific molecules as well as the expiration of patents stimulate the discovery and development of biosimilar and biosuperior/biobetter molecules.



Research Findings

Total sales of recombinant therapeutic monoclonal antibodies originating from companies located in regulated markets reached US$ 75.7 bln in the year 2013. Cumulated 2013 sales of branded therapeutic antibodies approaching patent expiry and, therefore, target of biosimilar substitution, reached US$ 58.6 bln.

The report lists specifically for each target the branded products with their 2013 sales and up-side indications in development, as well as follower, biosuperior and biosimilar antibody drug candidates in development.



Competitor projects are listed in a tabular format providing information on:

Drug Codes,

Target / Mechanism of Action,

Class of Compound,

Company,

Product Category,

Indication,

R&D Stage



Report Coverage

1. 2013 Sales of Recombinant Therapeutic Antibodies

2. CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors

3. Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors

4. VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors

5. EGF-R Antibodies –Biosimilars and Biosuperiors

6. TNF Antibodies –Biosimilars and Biosuperiors

7. IgE Antibodies: Xolair, Biosuperiors & Biosimilars

8. Interleukin-6 Receptor (IL-6R) Antibodies: Actemra, Biosuperiors & Biosimilars

9. GPIIb/IIIa Antibodies: ReoPro, Biosuperios & Biosimilars

For more details regarding Report coverage see the last slide




Report Coverage Continues…

10. CD52 Antibodies: Lemtrada, Biosuperios & Biosimilars

11. Apha4/beta1/7 Antibodies: Tysabri, Biosuperiors & Biosimilars

12. Complement C5 Antibodies: Soliris, Biosuperiors & Biosimilars

13. Respiratory Syncytial Virus (RSV): Synagis, Biosuperiors & Biosimilars

14. RANKL Antibodies: Prolia/XGEVA, Biosuperiors & Biosimilars

15. CD80/86 (B7-1/B7-2) Antibodies: Orencia; Nulojix, Biosuperiors & Biosimilars

16. Interleukin-12/-23 Antibodies: Stelara, Biosuperiors & Biosimilars

17. Corporate Biosimilar and Biosuperior Therapeutic Antibody Pipelines





Company Coverage (Partial List)

1. AbbVie2. Ablynx3. Actavis (Watson Pharmaceuticals)4. Actogenix5. ADC Therapeutics6. Affitech7. AIMM Therapeutics8. Alder Biopharmaceuticals9. Alexion Pharmaceuticals10. Allergan11. Allozyne12. Alopexx Oncology13. Alteogen14. Ambrx15. Amega Biotech





Custom Research: Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

http://www.marketresearchreports.com/idea-center



How To Buy This Report?

Visit following URL to see Table of Content and purchase this publication:

http://mrr.cm/Zoj

About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.

Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)

http://mrr.cm/Zoj

http://mrr.cm/Zoj

mailto:[email protected]


competitor analysis: biosimilar and biosuperior therapeutic antibodies 2014

Business